Cord Blood Cells.
Today medicine has reached great success in the treatment and prevention of many illnesses. Currently, scientists and doctors are paying more attention to technology of cells. Cord blood is the blood that remains in a newborn's umbilical cord after birth. Cord blood, like bone marrow, is an invaluable source of a type of stem cell that can be used in a variety of medical treatments. New parents now have the option of taking an active role in treating future illness much like a biological insurance policy. A process known as cord blood banking allows families to save these valuable resources for potential future medical use.
Currently, the clinical use of hemopoietic cells derived from bone marrow is the gold standard treatment for malignant and nonmalignant blood diseases after myeloablative therapy. However, use of BM has a number of logistical disadvantages that keep it from widespread use including inability to store cryogenically, difficult and invasive collection methods, high incidence of graftvs.-host-disease (GVHD), and stringent human leukocyte antigen (HLA)-matching requirements to prevent graft rejection. Research continues to reveal that umbilical cord blood (UCB) use can circumvent these complexities and has a potentially unrivaled degree of plasticity. What used to be a biological waste product is now seen as a source of therapeutic cells that the capability to treat a number of diseases and injuries. Since 1988 UCB has saved and extended the life of more than 60,000 people worldwide suffering from hemopoietic malignancies, marrow failure, and immunodeficiency disorders. UCB treatment becoming a clinical standard will require more efficient storage, recovery and expansion techniques, and a more thorough understanding of its mechanisms of action to ensure patient safety. Additionally, with more than 4 million babies born every year in the US alone, a campaign to educate future parents of the benefits of banking their newborn’s...
Please join StudyMode to read the full document